PAP
Persistent Asset Partners Portfolio holdings
AUM
$208M
1-Year Est. Return
95.31%
This Fund
S&P 500
1 Year Est. Return
+95.31%
AUM
$138M
AUM Growth
+$23.9M
(+21%)
Holding
264
Top Buys
| 1 | +$6.93M | |
| 2 | +$4.78M | |
| 3 | +$3.65M | |
| 4 |
CVS Health
CVS
|
+$3.53M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$3.17M |
Top Sells
| 1 | +$4.91M | |
| 2 | +$3.58M | |
| 3 | +$3.43M | |
| 4 |
Amgen
AMGN
|
+$3.35M |
| 5 |
Eli Lilly
LLY
|
+$2.53M |
Sector Composition
| 1 | Healthcare | 51.53% |
| 2 | Financials | 14.56% |
| 3 | Technology | 6.97% |
| 4 | Consumer Discretionary | 6.12% |
| 5 | Materials | 5.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Scholar Rock
SRRK
$4.65B
| – | – |
-14,314
|
|
||
252
iShares 20+ Year Treasury Bond BuyWrite Strategy ETF
TLTW
$1.81B
| – | – |
0
|
|
||
253
Tango Therapeutics
TNGX
$2.54B
| – | – |
0
|
|
||
254
Tesla
TSLA
$1.49T
| – | – |
0
|
|
||
255
Travere Therapeutics
TVTX
$2.54B
| – | – |
0
|
|
||
256
Uber
UBER
$162B
| – | – |
0
|
|
||
257
UMB Financial
UMBF
$8.44B
| – | – |
-9,391
|
|
||
|
VBTX
258
DELISTED
Veritex Holdings
VBTX
| – | – |
-7,980
|
|
||
259
Viridian Therapeutics
VRDN
$2.95B
| – | – |
-28,032
|
|
||
260
Vertex Pharmaceuticals
VRTX
$118B
| – | – |
-2,303
|
|
||
261
State Street SPDR NYSE Technology ETF
XNTK
$1.53B
| – | – |
0
|
|
||
262
Zillow
Z
$10.6B
| – | – |
-3,071
|
|
||
263
Zai Lab
ZLAB
$2.1B
| – | – |
-873
|
|